Loading
Life sciences · Journal article
Breast Cancer Research · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The senescence-associated secretory phenotype (SASP) is a major driver of chemotherapy-induced adverse effects in cancer therapy; however, its regulation through metabolic reprogramming in senescent cells remains poorly understood. In particular, the epigenetic mechanisms linking metabolic alterations to the chemotherapy-induced SASP have not been fully elucidated. In this study, metabolomic analysis demonstrated that chemotherapy-induced senescent breast cancer cells exhibit both enhanced respiratory potential and markedly increased lactate production. Genetic ablation or pharmacological inhibition of lactate dehydrogenase A (LDHA) significantly attenuated SASP expression. Moreover, LDHA depletion impaired the capacity of senescent cells to stimulate mammary tumor growth and inhibit dendritic cell (DC) infiltration within a co-inoculation xenograft model. Mechanistically, a screen of nine metabolism-related lysine post-translational modifications revealed a global increase in lysine lactylation (Kla) within senescent cells, with H3K9la, H3K14la, and H3K18la being significantly upregulated. Integrated CUT&Tag-seq and ATAC-seq analyses identified increased enrichment of H3K9la and H3K18la at SASP gene loci, coinciding with enhanced chromatin accessibility at their respective promoters. Finally, we identified general control nonderepressible 5 (GCN5) and P300/CBP-associated factor (PCAF) as lactyltransferases in senescent cells; either knockdown or pharmacological inhibition of GCN5 or PCAF reduced H3K9la and H3K18la levels, subsequently suppressing SASP transcription and secretion. Collectively, our findings delineate the metabolic landscape of senescent breast cancer cells and establish a mechanistic framework linking lactate production, histone H3 lactylation, and SASP regulation.